Structure

Physi-Chem Properties

Molecular Weight:  286.12
Volume:  302.181
LogP:  2.847
LogD:  3.057
LogS:  -3.312
# Rotatable Bonds:  5
TPSA:  58.92
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.884
Synthetic Accessibility Score:  2.389
Fsp3:  0.176
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.749
MDCK Permeability:  1.92112238437403e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.036
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.008

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.158
Plasma Protein Binding (PPB):  97.82001495361328%
Volume Distribution (VD):  0.561
Pgp-substrate:  2.0553836822509766%

ADMET: Metabolism

CYP1A2-inhibitor:  0.981
CYP1A2-substrate:  0.875
CYP2C19-inhibitor:  0.786
CYP2C19-substrate:  0.421
CYP2C9-inhibitor:  0.658
CYP2C9-substrate:  0.923
CYP2D6-inhibitor:  0.682
CYP2D6-substrate:  0.858
CYP3A4-inhibitor:  0.656
CYP3A4-substrate:  0.457

ADMET: Excretion

Clearance (CL):  6.674
Half-life (T1/2):  0.829

ADMET: Toxicity

hERG Blockers:  0.081
Human Hepatotoxicity (H-HT):  0.059
Drug-inuced Liver Injury (DILI):  0.066
AMES Toxicity:  0.059
Rat Oral Acute Toxicity:  0.053
Maximum Recommended Daily Dose:  0.036
Skin Sensitization:  0.947
Carcinogencity:  0.45
Eye Corrosion:  0.009
Eye Irritation:  0.92
Respiratory Toxicity:  0.37

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC58164

Natural Product ID:  NPC58164
Common Name*:   Macharistol
IUPAC Name:   2,4-dimethoxy-5-[(E)-3-phenylprop-2-enyl]benzene-1,3-diol
Synonyms:   macharistol
Standard InCHIKey:  UNXRJDKKDAMIOH-RMKNXTFCSA-N
Standard InCHI:  InChI=1S/C17H18O4/c1-20-16-13(11-14(18)17(21-2)15(16)19)10-6-9-12-7-4-3-5-8-12/h3-9,11,18-19H,10H2,1-2H3/b9-6+
SMILES:  COc1c(C/C=C/c2ccccc2)cc(c(c1O)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL523511
PubChem CID:   10085384
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0003496] Cinnamylphenols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27571 Machaerium aristulatum Species Dolichopodidae Eukaryota stems n.a. n.a. PMID[11720542]
NPO27571 Machaerium aristulatum Species Dolichopodidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens EC50 = 1.7 ug.mL-1 PMID[464571]
NPT1851 Cell Line Col2 Homo sapiens EC50 = 3.0 ug.mL-1 PMID[464571]
NPT858 Cell Line LNCaP Homo sapiens EC50 = 2.4 ug.mL-1 PMID[464571]
NPT737 Cell Line HUVEC Homo sapiens EC50 = 1.3 ug.mL-1 PMID[464571]
NPT91 Cell Line KB Homo sapiens GI = 23.0 % PMID[464571]
NPT91 Cell Line KB Homo sapiens GI = 0.0 % PMID[464571]
NPT1851 Cell Line Col2 Homo sapiens GI = 35.0 % PMID[464571]
NPT27 Others Unspecified EC50 = 3.0 ug.mL-1 PMID[464571]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 31.0 % PMID[464571]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 45.0 % PMID[464571]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC58164 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC10225
0.9919 High Similarity NPC51840
0.9919 High Similarity NPC299221
0.9919 High Similarity NPC311680
0.9919 High Similarity NPC234488
0.976 High Similarity NPC6451
0.9756 High Similarity NPC266691
0.9754 High Similarity NPC18924
0.9754 High Similarity NPC28730
0.9754 High Similarity NPC78974
0.9754 High Similarity NPC223136
0.9754 High Similarity NPC103823
0.9754 High Similarity NPC214406
0.9754 High Similarity NPC44748
0.968 High Similarity NPC474356
0.968 High Similarity NPC232275
0.968 High Similarity NPC45715
0.968 High Similarity NPC12275
0.9675 High Similarity NPC169474
0.9675 High Similarity NPC159968
0.9675 High Similarity NPC236791
0.9675 High Similarity NPC246620
0.9675 High Similarity NPC282000
0.9675 High Similarity NPC124452
0.9675 High Similarity NPC293054
0.9675 High Similarity NPC324112
0.9675 High Similarity NPC74817
0.9675 High Similarity NPC82679
0.9672 High Similarity NPC234400
0.9672 High Similarity NPC299584
0.9672 High Similarity NPC60885
0.9672 High Similarity NPC82483
0.9672 High Similarity NPC265483
0.96 High Similarity NPC214860
0.96 High Similarity NPC192687
0.96 High Similarity NPC224157
0.959 High Similarity NPC183446
0.9531 High Similarity NPC472337
0.952 High Similarity NPC190144
0.952 High Similarity NPC45824
0.9512 High Similarity NPC193544
0.9512 High Similarity NPC475169
0.9512 High Similarity NPC105925
0.9512 High Similarity NPC233410
0.9512 High Similarity NPC221077
0.9512 High Similarity NPC17943
0.9512 High Similarity NPC251855
0.9512 High Similarity NPC208950
0.9512 High Similarity NPC116907
0.9512 High Similarity NPC472093
0.9512 High Similarity NPC57490
0.9512 High Similarity NPC203133
0.9512 High Similarity NPC117214
0.9512 High Similarity NPC298757
0.9508 High Similarity NPC95168
0.9457 High Similarity NPC472336
0.9457 High Similarity NPC472334
0.9444 High Similarity NPC126836
0.944 High Similarity NPC28765
0.944 High Similarity NPC154866
0.9435 High Similarity NPC112596
0.9426 High Similarity NPC262253
0.9426 High Similarity NPC473411
0.9426 High Similarity NPC71579
0.9385 High Similarity NPC90615
0.9385 High Similarity NPC103976
0.9385 High Similarity NPC6262
0.9385 High Similarity NPC326797
0.9385 High Similarity NPC276490
0.9385 High Similarity NPC474282
0.9385 High Similarity NPC107551
0.9385 High Similarity NPC201145
0.9385 High Similarity NPC73535
0.9385 High Similarity NPC272157
0.9385 High Similarity NPC102904
0.9385 High Similarity NPC176051
0.9385 High Similarity NPC25111
0.9375 High Similarity NPC229442
0.9375 High Similarity NPC168059
0.9365 High Similarity NPC170844
0.9365 High Similarity NPC212015
0.9365 High Similarity NPC476968
0.936 High Similarity NPC216836
0.936 High Similarity NPC252131
0.936 High Similarity NPC236760
0.936 High Similarity NPC210355
0.936 High Similarity NPC127587
0.936 High Similarity NPC266555
0.935 High Similarity NPC228922
0.935 High Similarity NPC282496
0.935 High Similarity NPC136319
0.935 High Similarity NPC233526
0.935 High Similarity NPC121115
0.935 High Similarity NPC197757
0.9344 High Similarity NPC75713
0.9344 High Similarity NPC285289
0.9313 High Similarity NPC79622
0.9313 High Similarity NPC245207
0.9313 High Similarity NPC212942
0.9313 High Similarity NPC29868
0.9313 High Similarity NPC319647
0.9313 High Similarity NPC127218
0.9313 High Similarity NPC25966
0.9308 High Similarity NPC300846
0.9308 High Similarity NPC476639
0.9308 High Similarity NPC114155
0.9302 High Similarity NPC310854
0.9302 High Similarity NPC106215
0.9297 High Similarity NPC127624
0.9297 High Similarity NPC86655
0.9297 High Similarity NPC202762
0.9286 High Similarity NPC470213
0.9286 High Similarity NPC186843
0.9286 High Similarity NPC98631
0.9286 High Similarity NPC206615
0.928 High Similarity NPC76451
0.928 High Similarity NPC223953
0.9268 High Similarity NPC41562
0.9268 High Similarity NPC246967
0.9268 High Similarity NPC135414
0.9268 High Similarity NPC474864
0.9262 High Similarity NPC166759
0.9242 High Similarity NPC160283
0.9242 High Similarity NPC254759
0.9242 High Similarity NPC73505
0.9242 High Similarity NPC284464
0.9242 High Similarity NPC165026
0.9242 High Similarity NPC295719
0.9242 High Similarity NPC34431
0.9231 High Similarity NPC283009
0.9231 High Similarity NPC474206
0.9231 High Similarity NPC121812
0.9231 High Similarity NPC201357
0.9231 High Similarity NPC256262
0.9231 High Similarity NPC195022
0.9231 High Similarity NPC134968
0.9231 High Similarity NPC94750
0.9231 High Similarity NPC112246
0.9231 High Similarity NPC261873
0.9231 High Similarity NPC255147
0.9231 High Similarity NPC281521
0.9231 High Similarity NPC111655
0.9231 High Similarity NPC112939
0.9231 High Similarity NPC470356
0.9225 High Similarity NPC475840
0.9225 High Similarity NPC471391
0.9225 High Similarity NPC32778
0.9225 High Similarity NPC37196
0.9225 High Similarity NPC94236
0.9225 High Similarity NPC471390
0.9219 High Similarity NPC474017
0.9219 High Similarity NPC470095
0.9219 High Similarity NPC472597
0.9219 High Similarity NPC470096
0.9206 High Similarity NPC242032
0.918 High Similarity NPC247364
0.918 High Similarity NPC61516
0.918 High Similarity NPC10932
0.918 High Similarity NPC232084
0.918 High Similarity NPC474565
0.9173 High Similarity NPC471389
0.9167 High Similarity NPC30951
0.9167 High Similarity NPC6369
0.9167 High Similarity NPC292882
0.916 High Similarity NPC143139
0.916 High Similarity NPC205442
0.916 High Similarity NPC474639
0.916 High Similarity NPC270456
0.916 High Similarity NPC162659
0.916 High Similarity NPC202846
0.916 High Similarity NPC248727
0.916 High Similarity NPC306441
0.916 High Similarity NPC230734
0.916 High Similarity NPC173660
0.916 High Similarity NPC16435
0.916 High Similarity NPC227503
0.916 High Similarity NPC265433
0.9154 High Similarity NPC276026
0.9154 High Similarity NPC7515
0.9154 High Similarity NPC206737
0.9154 High Similarity NPC56764
0.9154 High Similarity NPC469659
0.9154 High Similarity NPC555
0.9154 High Similarity NPC188378
0.9154 High Similarity NPC289258
0.9154 High Similarity NPC317380
0.9154 High Similarity NPC103967
0.9147 High Similarity NPC253105
0.9147 High Similarity NPC7903
0.9147 High Similarity NPC35932
0.9147 High Similarity NPC161203
0.9147 High Similarity NPC160991
0.9147 High Similarity NPC16208
0.9147 High Similarity NPC184447
0.9147 High Similarity NPC201587
0.9141 High Similarity NPC472338
0.9141 High Similarity NPC91291
0.9141 High Similarity NPC220935
0.912 High Similarity NPC206487
0.912 High Similarity NPC5796

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC58164 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9365 High Similarity NPD3027 Phase 3
0.8984 High Similarity NPD1529 Clinical (unspecified phase)
0.8906 High Similarity NPD1530 Clinical (unspecified phase)
0.8855 High Similarity NPD1612 Clinical (unspecified phase)
0.8855 High Similarity NPD1613 Approved
0.8615 High Similarity NPD3018 Phase 2
0.845 Intermediate Similarity NPD2982 Phase 2
0.845 Intermediate Similarity NPD2983 Phase 2
0.8443 Intermediate Similarity NPD228 Approved
0.8372 Intermediate Similarity NPD2981 Phase 2
0.8356 Intermediate Similarity NPD2801 Approved
0.8168 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD5283 Phase 1
0.8134 Intermediate Similarity NPD4908 Phase 1
0.8125 Intermediate Similarity NPD1548 Phase 1
0.8041 Intermediate Similarity NPD1934 Approved
0.8015 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8015 Intermediate Similarity NPD1610 Phase 2
0.8014 Intermediate Similarity NPD1653 Approved
0.7943 Intermediate Similarity NPD3540 Phase 1
0.7926 Intermediate Similarity NPD2861 Phase 2
0.7881 Intermediate Similarity NPD3882 Suspended
0.7872 Intermediate Similarity NPD3539 Phase 1
0.7867 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD1511 Approved
0.784 Intermediate Similarity NPD3021 Approved
0.784 Intermediate Similarity NPD3022 Approved
0.781 Intermediate Similarity NPD4625 Phase 3
0.777 Intermediate Similarity NPD1558 Phase 1
0.7761 Intermediate Similarity NPD4749 Approved
0.7755 Intermediate Similarity NPD1512 Approved
0.7752 Intermediate Similarity NPD6671 Approved
0.7662 Intermediate Similarity NPD6234 Discontinued
0.7647 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD6166 Phase 2
0.7635 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD5536 Phase 2
0.763 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7626 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7623 Intermediate Similarity NPD1242 Phase 1
0.7619 Intermediate Similarity NPD4357 Discontinued
0.7612 Intermediate Similarity NPD3705 Approved
0.7612 Intermediate Similarity NPD422 Phase 1
0.7603 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7591 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD3817 Phase 2
0.7566 Intermediate Similarity NPD37 Approved
0.7561 Intermediate Similarity NPD940 Approved
0.7561 Intermediate Similarity NPD846 Approved
0.755 Intermediate Similarity NPD4678 Approved
0.755 Intermediate Similarity NPD4675 Approved
0.7518 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7518 Intermediate Similarity NPD4060 Phase 1
0.7518 Intermediate Similarity NPD3620 Phase 2
0.7516 Intermediate Similarity NPD6232 Discontinued
0.75 Intermediate Similarity NPD7054 Approved
0.75 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2935 Discontinued
0.7484 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD2219 Phase 1
0.7481 Intermediate Similarity NPD1091 Approved
0.7466 Intermediate Similarity NPD3060 Approved
0.746 Intermediate Similarity NPD968 Approved
0.7453 Intermediate Similarity NPD7472 Approved
0.7453 Intermediate Similarity NPD7074 Phase 3
0.7448 Intermediate Similarity NPD7266 Discontinued
0.7447 Intermediate Similarity NPD2674 Phase 3
0.7438 Intermediate Similarity NPD3818 Discontinued
0.7432 Intermediate Similarity NPD7124 Phase 2
0.7423 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7422 Intermediate Similarity NPD4750 Phase 3
0.7419 Intermediate Similarity NPD4967 Phase 2
0.7419 Intermediate Similarity NPD4965 Approved
0.7419 Intermediate Similarity NPD4966 Approved
0.7394 Intermediate Similarity NPD1240 Approved
0.7391 Intermediate Similarity NPD5844 Phase 1
0.7388 Intermediate Similarity NPD1357 Approved
0.7375 Intermediate Similarity NPD7473 Discontinued
0.7368 Intermediate Similarity NPD4005 Discontinued
0.7347 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD5177 Phase 3
0.7344 Intermediate Similarity NPD2684 Approved
0.7343 Intermediate Similarity NPD230 Phase 1
0.7342 Intermediate Similarity NPD7199 Phase 2
0.7333 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD7228 Approved
0.732 Intermediate Similarity NPD4380 Phase 2
0.7319 Intermediate Similarity NPD2922 Phase 1
0.731 Intermediate Similarity NPD1510 Phase 2
0.7301 Intermediate Similarity NPD6797 Phase 2
0.7292 Intermediate Similarity NPD1607 Approved
0.729 Intermediate Similarity NPD1465 Phase 2
0.7279 Intermediate Similarity NPD3496 Discontinued
0.7278 Intermediate Similarity NPD5494 Approved
0.7273 Intermediate Similarity NPD943 Approved
0.7267 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7266 Intermediate Similarity NPD290 Approved
0.7261 Intermediate Similarity NPD4055 Discovery
0.7256 Intermediate Similarity NPD7251 Discontinued
0.7254 Intermediate Similarity NPD3145 Approved
0.7254 Intermediate Similarity NPD3144 Approved
0.7252 Intermediate Similarity NPD7843 Approved
0.725 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD6190 Approved
0.7241 Intermediate Similarity NPD6111 Discontinued
0.7237 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD6674 Discontinued
0.723 Intermediate Similarity NPD4236 Phase 3
0.723 Intermediate Similarity NPD4237 Approved
0.723 Intermediate Similarity NPD1652 Phase 2
0.7219 Intermediate Similarity NPD4123 Phase 3
0.7219 Intermediate Similarity NPD7447 Phase 1
0.7218 Intermediate Similarity NPD7157 Approved
0.7213 Intermediate Similarity NPD9296 Approved
0.7213 Intermediate Similarity NPD2933 Approved
0.7213 Intermediate Similarity NPD2934 Approved
0.7212 Intermediate Similarity NPD7549 Discontinued
0.7212 Intermediate Similarity NPD7808 Phase 3
0.7203 Intermediate Similarity NPD6233 Phase 2
0.7194 Intermediate Similarity NPD8651 Approved
0.7194 Intermediate Similarity NPD6696 Suspended
0.7179 Intermediate Similarity NPD2977 Approved
0.7179 Intermediate Similarity NPD2978 Approved
0.7163 Intermediate Similarity NPD9494 Approved
0.7162 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7154 Intermediate Similarity NPD2859 Approved
0.7154 Intermediate Similarity NPD2860 Approved
0.7153 Intermediate Similarity NPD2238 Phase 2
0.7152 Intermediate Similarity NPD6799 Approved
0.7152 Intermediate Similarity NPD7213 Phase 3
0.7152 Intermediate Similarity NPD7212 Phase 2
0.7143 Intermediate Similarity NPD6099 Approved
0.7143 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6100 Approved
0.7134 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD5402 Approved
0.7133 Intermediate Similarity NPD5110 Phase 2
0.7133 Intermediate Similarity NPD5111 Phase 2
0.7133 Intermediate Similarity NPD5109 Approved
0.7133 Intermediate Similarity NPD2677 Approved
0.7126 Intermediate Similarity NPD8053 Approved
0.7126 Intermediate Similarity NPD8054 Approved
0.7123 Intermediate Similarity NPD4538 Approved
0.7123 Intermediate Similarity NPD4536 Approved
0.7123 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD3020 Approved
0.7113 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD6584 Phase 3
0.7091 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD4626 Approved
0.7067 Intermediate Similarity NPD3892 Phase 2
0.7067 Intermediate Similarity NPD3750 Approved
0.7063 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD7095 Approved
0.7051 Intermediate Similarity NPD5090 Approved
0.7051 Intermediate Similarity NPD5089 Approved
0.705 Intermediate Similarity NPD2232 Approved
0.705 Intermediate Similarity NPD2233 Approved
0.705 Intermediate Similarity NPD2230 Approved
0.7047 Intermediate Similarity NPD1549 Phase 2
0.7044 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD7075 Discontinued
0.7023 Intermediate Similarity NPD5451 Approved
0.7014 Intermediate Similarity NPD5718 Phase 2
0.7014 Intermediate Similarity NPD6798 Discontinued
0.7 Intermediate Similarity NPD4162 Approved
0.6993 Remote Similarity NPD1424 Approved
0.6993 Remote Similarity NPD600 Approved
0.6993 Remote Similarity NPD596 Approved
0.6992 Remote Similarity NPD7635 Approved
0.6986 Remote Similarity NPD447 Suspended
0.6986 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6986 Remote Similarity NPD6355 Discontinued
0.6986 Remote Similarity NPD5124 Phase 1
0.6981 Remote Similarity NPD6788 Approved
0.698 Remote Similarity NPD1375 Discontinued
0.6978 Remote Similarity NPD1535 Discovery
0.697 Remote Similarity NPD9280 Clinical (unspecified phase)
0.6966 Remote Similarity NPD839 Approved
0.6966 Remote Similarity NPD840 Approved
0.6963 Remote Similarity NPD709 Approved
0.6962 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6959 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6959 Remote Similarity NPD5960 Phase 3
0.6959 Remote Similarity NPD5588 Approved
0.6959 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6516 Phase 2
0.6957 Remote Similarity NPD5846 Approved
0.6954 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6948 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6939 Remote Similarity NPD4097 Suspended
0.6929 Remote Similarity NPD1481 Phase 2
0.6928 Remote Similarity NPD5297 Approved
0.6928 Remote Similarity NPD1774 Approved
0.6923 Remote Similarity NPD7261 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data